Skip to main content
SleepCited

Restless Legs Syndrome: clinical features, diagnosis and a practical approach to management.

Subhashie Wijemanne, William Ondo
Review Practical neurology 2017 69 citations

Study Design

Study Type
Review
Population
Patients with restless legs syndrome
Intervention
Restless Legs Syndrome: clinical features, diagnosis and a practical approach to management. 75 µg
Primary Outcome
RLS symptom management and augmentation prevention
Effect Direction
Mixed
Risk of Bias
Unclear

Abstract

Restless legs syndrome (RLS) is a chronic neurological disorder that interferes with rest and sleep. It has a wide spectrum of symptom severity, and treatment is started when symptoms become bothersome. Dopamine agonists and calcium channel apha-2-delta antagonists (gabapentin, gabapentin enacarbil and pregabalin) are first-line treatments; calcium channel alpha-2-deltas are preferred over dopamine agonists because they give less augmentation, a condition with symptom onset earlier in the day and intensification of RLS symptoms. Dopamine agonists can still be used as first-line therapy, but the dose should be kept as low as possible. Iron supplements are started when the serum ferritin concentration is ≤75 µg/L, or if the transferrin saturation is less than 20%. For severe or resistant RLS, a combined treatment approach can be effective. Augmentation can be very challenging to treat and lacks evidenced-based guidelines.

TL;DR

For severe or resistant RLS, a combined treatment approach can be effective, and augmentation can be very challenging to treat and lacks evidenced-based guidelines.

Used In Evidence Reviews

Similar Papers

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.